Belimumab for the treatment of recalcitrant cutaneous lupus

Cutaneous Lupus Erythematosus: An Update on Pathogenesis, Diagnosis and Treatment

(2016) Emily Z. Hejazi et al.   AMERICAN JOURNAL OF CLINICAL DERMATOLOGY

A Retrospective Administrative Claims Database Evaluation of the Utilization of Belimumab in US Managed Care Settings

(2015) Xuehua Ke et al.   CLINICAL THERAPEUTICS

A pilot study to determine the optimal timing of the Physician Global Assessment (PGA) in patients with systemic lupus erythematosus

(2015) Cynthia Aranow   IMMUNOLOGIC RESEARCH

Post-marketing Experiences with Belimumab in the Treatment of SLE Patients

(2014) Anca D. Askanase et al.   RHEUMATIC DISEASE CLINICS OF NORTH AMERICA

Improvements in health-related quality of life with belimumab, a B-lymphocyte stimulator-specific inhibitor, in patients with autoantibody-positive systemic lupus erythematosus from the randomised controlled BLISS trials

(2013) Vibeke Strand et al.   ANNALS OF THE RHEUMATIC DISEASES

Disease Control and Safety of Belimumab Plus Standard Therapy Over 7 Years in Patients with Systemic Lupus Erythematosus

(2013) E. M. Ginzler et al.   JOURNAL OF RHEUMATOLOGY

Belimumab in the treatment of systemic lupus erythematosus: high disease activity predictors of response

(2012) Ronald F van Vollenhoven et al.   ANNALS OF THE RHEUMATIC DISEASES

Effects of belimumab, a B lymphocyte stimulator-specific inhibitor, on disease activity across multiple organ domains in patients with systemic lupus erythematosus: combined results from two phase III trials

(2012) Susan Manzi et al.   ANNALS OF THE RHEUMATIC DISEASES

A phase III, randomized, placebo-controlled study of belimumab, a monoclonal antibody that inhibits B lymphocyte stimulator, in patients with systemic lupus erythematosus

(2011) Richard Furie et al.   ARTHRITIS AND RHEUMATISM

Efficacy and safety of belimumab in patients with active systemic lupus erythematosus: a randomised, placebo-controlled, phase 3 trial

(2011) Sandra V Navarra et al.   LANCET

Overview of common, rare and atypical manifestations of cutaneous lupus erythematosus and histopathological correlates

(2010) G. Obermoser et al.   LUPUS

Cutaneous lupus erythematosus: clinical and immunological study of 308 patients stratified by gender

(2009) M. A. Vera-Recabarren et al.   CLINICAL AND EXPERIMENTAL DERMATOLOGY